Can a serious infection let old viruses escape control?
Yes. In 1,154 patients hospitalized with COVID-19, dormant viruses became active again during the acute illness, and that virus reactivation tracked with how sick people became.
Most of us carry viruses that never left. After a first infection, some viruses settle into a sleeping state inside your cells and stay there for life. The researchers note that people carry multiple such viruses at any given time, and most of the time they cause no symptoms at all. The two families that matter most here are the herpes viruses, which include Epstein-Barr virus, cytomegalovirus and herpes simplex virus 1, and a group called anelloviruses, which are usually considered harmless passengers.
This study asked a simple question with a large dataset. When the body is hit hard by a new infection, do those sleeping viruses wake up, and does it matter?
What the Data Show
Reactivation was common. Across the 1,154 hospitalized patients in this cohort, the herpes viruses and the anelloviruses both showed significant reactivation during acute COVID-19.
Each virus had its own timeline. The researchers describe distinct temporal dynamics for the different viruses, so Epstein-Barr virus, herpes simplex virus 1 and cytomegalovirus did not all wake up on the same schedule.
Dr. Kumar’s Take
What I find most useful here is the timing. This is not a snapshot from one blood draw, which is how most earlier work on this question was done. The team measured actively made viral RNA across a year, in blood, in the nose and in the lungs of ventilated patients, so we finally get a real curve rather than a single dot.
I want to be careful about what this does and does not prove. The authors are direct that they cannot show these viruses caused worse outcomes. A sicker body may simply lose grip on viruses it was already holding down. But a few details push against pure coincidence. Inflammatory signals such as interleukin-6 and interleukin-10 were higher in people with reactivation even after accounting for how severe their COVID was. And Epstein-Barr antibody levels were already elevated at admission, which suggests that virus stirred before the worst of the illness, not after.
Reactivation Tracked With How Sick People Got
Virus reactivation lined up with COVID-19 severity across the board. Epstein-Barr virus in blood showed the strongest link to severity, with far less than a one in a million chance of being coincidence.
Among the critically ill, the viruses also tracked with dying within a year. Reactivation was also tied to specific complications, including shock, intensive care admission, blood clots in the veins, liver failure and additional infections.
This Is Not Just an Immune-Suppressed Problem
The usual assumption is that sleeping viruses only wake up in people whose immune systems are weakened by transplant drugs or chemotherapy. This cohort argues otherwise. Anelloviruses reactivated in immunocompetent patients, not only in people taking immunosuppressive medication.
For the herpes viruses, the researchers found no link at all between reactivation and being immunosuppressed, even though there was a clear link with severity. Their read is that severe illness by itself is enough to loosen the body’s control over these viruses.
The Long COVID Signal
During the acute hospital stay, virus reactivation did not predict which patients would later report lasting symptoms. The picture changed during recovery. Among people sampled two or more months after admission, anelloviruses in the blood were more common in the group reporting lasting physical problems, meaning reduced physical function and fatigue rather than brain fog.
The authors suggest anellovirus transcripts may work as a marker for persistent physical disability in long COVID.
Limits Worth Knowing
This is an observational study, so it can show patterns but not causes. Everyone enrolled was hospitalized with COVID-19, so these findings may not describe mild infection managed at home. The long COVID sample was also thinner than the acute one, partly because sicker patients died or dropped out. And because these viruses hide in tissue rather than blood, testing blood likely undercounts reactivation rather than overstating it.
Practical Takeaways
- If you or a family member is hospitalized with a severe infection and develops shock, kidney trouble or a stubborn second infection, it is reasonable to ask the team whether reactivation of a virus like cytomegalovirus has been considered.
- Do not read this as a reason to seek antiviral drugs on your own, since the study measured associations only and did not test whether treating reactivation improves anything.
- If you have lasting physical fatigue and weakness after COVID, know that a measurable biological signal is being investigated, and that this line of research is aimed at prediction rather than treatment so far.
Related Studies and Research
- Epstein-Barr virus leaves an immune fingerprint in multiple sclerosis
- Long daytime naps linked to higher death risk in older adults
- Does high LDL-C help elderly people live longer? A review of 19 studies
- Low vitamin D is linked to worse, longer-lasting tendon pain
FAQs
What are anelloviruses, and should I worry about carrying them?
Anelloviruses are extremely common viruses that most healthy adults carry without any symptoms. They have long been treated as harmless passengers, and some researchers use their levels as a rough gauge of how active a person’s immune system is. In this study they were the virus family most often found months after hospitalization, and they were the one tied to lasting physical problems. That does not make them dangerous on their own, and there is no test or treatment for them in routine care.
Does this mean COVID gave me mono or shingles?
Not necessarily. The researchers measured viral genetic material being actively produced, which is a much more sensitive signal than a visible outbreak. Reactivation at this level is a biological event that blood and swab testing can catch well before, and often instead of, any recognizable symptoms.
Would being vaccinated change these results?
We cannot tell from this data. Hospitalization with COVID-19 was the entry requirement for every participant. Since vaccination lowers the odds of severe COVID, and severity is what tracked most strongly with reactivation, it is reasonable to expect less reactivation in a vaccinated group. That expectation still needs to be tested directly in a vaccinated cohort.
Bottom Line
In the largest look at this question so far, hospitalized COVID-19 patients commonly had a dormant virus reactivate, and that reactivation lined up with severity, complications and death among the critically ill. It happened in people with normal immune systems, not only the immunosuppressed, which upends the standard assumption. Months later, anelloviruses in the blood stood out in patients reporting lasting physical disability. Nothing here proves cause and effect, but it points to virus reactivation as a measurable signal worth tracking in severe infection.
